Fosco1 Thank you so much for your explanation! That makes a lot of sense to me. Guess that's why we have a Phase 3 then, to continue testing in depth.
One more question I want to clarify. It was mentioned that in the Phase 2 study, that when Multikine was injected into patients, it was combined with a chemotherapy drug. And because of this there was no way to know whether it was Multikine that was shrinking the tumors or the chemotherapy drug. Is this true? Or is there further information to prove that Multikine was indeed having the positive effect of shrinking tumors?
News 
Market Data 
Discover 
